$NIC
NICOLET BANKSHARES INC Stock $nic

$nic Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000117485020000032 Filed on April 30, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$37.00M	$33.16M
YoY Change	11.59%	7.71%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.200M	$1.100M
YoY Change	100.0%	-35.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$5.740M	$5.684M
YoY Change	0.99%	45.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$13.99M	$13.70M
YoY Change	2.13%	9.21%
Income Tax	$3.321M	$3.352M
% Of Pretax Income	23.73%	24.46%
Net Earnings	$10.56M	$10.27M
YoY Change	2.81%	7.2%
Net Earnings / Revenue	28.52%	30.96%
Basic Earnings Per Share	$1.00	$1.09
Diluted Earnings Per Share	$0.98	$1.05
COMMON SHARES
Basic Shares Outstanding	10.52M shares	9.461M shares
Diluted Shares Outstanding	10.80M shares	9.758M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$242.0M	$154.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$60.28M	$49.44M
YoY Change	21.91%	6.79%
Goodwill	$151.2M	$107.4M
YoY Change	40.82%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$3.733B	$3.041B
YoY Change	22.74%	-5.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$39.60M	$25.60M
YoY Change	54.69%	49.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$75.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$114.6M	$25.60M
YoY Change	347.66%	49.71%
LONG-TERM LIABILITIES
Long-Term Debt	$42.70M	$42.20M
YoY Change	1.18%	1.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$42.70M	$42.20M
YoY Change	1.18%	1.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$114.6M	$25.60M
Total Long-Term Liabilities	$42.70M	$42.20M
Total Liabilities	$3.221B	$2.641B
YoY Change	21.93%	-7.64%
SHAREHOLDERS EQUITY
Retained Earnings	$203.4M	$154.6M
YoY Change	31.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$511.0M	$398.8M
YoY Change
Total Liabilities & Shareholders Equity	$3.733B	$3.041B
YoY Change	22.74%	-5.67%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$10.56M	$10.27M
YoY Change	2.81%	7.2%
Depreciation, Depletion And Amortization	$2.200M	$1.100M
YoY Change	100.0%	-35.29%
Cash From Operating Activities	$12.17M	$10.30M
YoY Change	18.14%	27.82%
INVESTING ACTIVITIES
Capital Expenditures	$5.000M	$2.400M
YoY Change	108.33%	500.0%
Acquisitions
YoY Change
Other Investing Activities	-$92.20M	-$22.10M
YoY Change	317.19%	48.32%
Cash From Investing Activities	-$97.20M	-$24.51M
YoY Change	296.57%	59.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$14.98M	$5.534M
YoY Change	170.73%	1057.74%
Debt Paid & Issued, Net	$5.000M	$64.00K
YoY Change	7712.5%	-93.97%
Cash From Financing Activities	$144.9M	-$80.55M
YoY Change	-279.93%	-128.23%
NET CHANGE
Cash From Operating Activities	$12.17M	$10.30M
Cash From Investing Activities	-$97.20M	-$24.51M
Cash From Financing Activities	$144.9M	-$80.55M
Net Change In Cash	$59.90M	-$94.77M
YoY Change	-163.21%	-134.08%
FREE CASH FLOW
Cash From Operating Activities	$12.17M	$10.30M
Capital Expenditures	$5.000M	$2.400M
Free Cash Flow	$7.165M	$7.897M
YoY Change	-9.27%	3.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	ncbs	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	3750000	USD
CY2020Q1	ncbs	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	4204000	USD
CY2019Q4	ncbs	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0054
CY2020Q1	ncbs	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0100
CY2019	ncbs	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2020Q1	ncbs	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2019Q4	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1
CY2020Q1	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1
CY2019Q4	ncbs	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2020Q1	ncbs	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2019Q4	ncbs	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2020Q1	ncbs	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2020Q1	ncbs	Pledged Assets Separately Reported Restricted Cash Pledged As Collateral PledgedAssetsSeparatelyReportedRestrictedCashPledgedAsCollateral	1900000	USD
CY2019Q4	ncbs	Time Deposit In Other Banks TimeDepositInOtherBanks	19305000	USD
CY2020Q1	ncbs	Time Deposit In Other Banks TimeDepositInOtherBanks	18804000	USD
CY2019Q4	ncbs	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	29400000	USD
CY2020Q1	ncbs	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	29500000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4418000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7579000	USD
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001174850
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10412885	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	NICOLET BANKSHARES INC
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	ncbs	Accretion Discount AccretionDiscount	6408000	USD
CY2019Q1	ncbs	Accretion Discount AccretionDiscount	6187000	USD
CY2019Q4	ncbs	Accretion Discount AccretionDiscount	1927000	USD
CY2019Q1	ncbs	Accretion To Loan Interest Income AccretionToLoanInterestIncome	221000	USD
CY2019	ncbs	Accretion To Loan Interest Income AccretionToLoanInterestIncome	4713000	USD
CY2019Q1	ncbs	Acquired Balance Net AcquiredBalanceNet	0	USD
CY2019	ncbs	Acquired Balance Net AcquiredBalanceNet	911000	USD
CY2020Q1	ncbs	Collateral Dependent Financing Receivable Related Allowance CollateralDependentFinancingReceivableRelatedAllowance	1744000	USD
CY2020Q1	ncbs	Collateral Dependent Financing Receivable Unpaid Principal Balance CollateralDependentFinancingReceivableUnpaidPrincipalBalance	11806000	USD
CY2020Q1	ncbs	Collateral Dependent Financing Receivable With No Related Allowance CollateralDependentFinancingReceivableWithNoRelatedAllowance	6371000	USD
CY2020Q1	ncbs	Collateral Dependent Financing Receivable With Related Allowance CollateralDependentFinancingReceivableWithRelatedAllowance	5435000	USD
CY2019Q1	ncbs	Disposals Of Loans DisposalsOfLoans	0	USD
CY2019	ncbs	Disposals Of Loans DisposalsOfLoans	679000	USD
CY2019Q4	ncbs	Financing Receivable Percent Nonaccrual FinancingReceivablePercentNonaccrual	0.005
CY2020Q1	ncbs	Financing Receivable Percent Nonaccrual FinancingReceivablePercentNonaccrual	0.006
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312733000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	299903000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1108000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1299000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	501478000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	35066000	USD
CY2020Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	139886000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	35929000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	235471000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	237604000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10424000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11392000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	301907000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	297903000	USD
CY2020Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	492152000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	16942000	USD
CY2020Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	304129000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	-654000	USD
CY2020Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	362840000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2552360000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2586525000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	14122000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	14769000	USD
CY2019Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1102000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	16982000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	449302000	USD
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	78140000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	78665000	USD
CY2020Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	456615000	USD
CY2019Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	459000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	703000	USD
CY2019Q1	us-gaap	Business Development BusinessDevelopment	1281000	USD
CY2020Q1	us-gaap	Business Development BusinessDevelopment	1359000	USD
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	75433000	USD
CY2020Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	53741000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249526000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154761000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182059000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241960000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-94765000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	59901000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10610259	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10428896	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10587738	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10408375	shares
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	106000	USD
CY2020Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	104000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15969000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13834000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	65967000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	28683000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	535000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	305000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	73112000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	38324000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	379000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	277000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	133000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	13000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	120000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	139079000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	67007000	USD
CY2019Q4	ncbs	Financing Receivable Recorded Investment Current Percentage Of Loan FinancingReceivableRecordedInvestmentCurrentPercentageOfLoan	0.992
CY2020Q1	ncbs	Financing Receivable Recorded Investment Current Percentage Of Loan FinancingReceivableRecordedInvestmentCurrentPercentageOfLoan	0.992
CY2020Q1	ncbs	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	3973000	USD
CY2019Q1	ncbs	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	1748000	USD
CY2020Q1	ncbs	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	5567000	USD
CY2019Q1	ncbs	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-1000	USD
CY2020Q1	ncbs	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-501000	USD
CY2019Q1	ncbs	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	-421000	USD
CY2020Q1	ncbs	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	-2257000	USD
CY2019Q4	ncbs	Long Term Debt Percentage Bearing Fixed Interest Rate Percentage LongTermDebtPercentageBearingFixedInterestRatePercentage	0.64
CY2020Q1	ncbs	Long Term Debt Percentage Bearing Fixed Interest Rate Percentage LongTermDebtPercentageBearingFixedInterestRatePercentage	0.70
CY2019Q4	ncbs	Longterm Debt Percentage Bearing Variable Interest Rate Percentage LongtermDebtPercentageBearingVariableInterestRatePercentage	0.36
CY2020Q1	ncbs	Longterm Debt Percentage Bearing Variable Interest Rate Percentage LongtermDebtPercentageBearingVariableInterestRatePercentage	0.30
CY2020Q1	ncbs	Material Loans Criteria For Acl Loans Adequacy Calculation MaterialLoansCriteriaForACLLoansAdequacyCalculation	250000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	914000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1100000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1053000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	993000	USD
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2019Q4	us-gaap	Assets Assets	3577260000	USD
CY2020Q1	us-gaap	Assets Assets	3732554000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6967000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10964000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	914000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	582000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	212	Security
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	582000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	443249000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	511860000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14769000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	91	Security
CY2019Q4	us-gaap	Deposits Deposits	2954453000	USD
CY2020Q1	us-gaap	Deposits Deposits	3023466000	USD
CY2019Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1108000	USD
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2156000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12800000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M27D
CY2019Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	1203000	USD
CY2020Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	2327000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	-17000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	4	Loan
CY2019	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	1100000	USD
CY2019	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	381000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	1100000	USD
CY2019	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	1400000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	1400000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	55000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13153000	USD
CY2020Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	641639000	USD
CY2020Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	206190000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13370000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13972000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	26202000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	27000	USD
CY2019	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	546000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	38000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	10000	USD
CY2019	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	927000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	93000	USD
CY2019Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	2355000	USD
CY2019	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	5	Loan
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	2563000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	165967000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13776000	USD
CY2019Q1	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	172000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	3017000	USD
CY2019Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	172000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-654000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	107366000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	151198000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	151198000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	44594000	USD
CY2020Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	762000	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	800000	USD
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16998000	USD
CY2019	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	2063000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	16891000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	741000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	20300000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13702000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13994000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3352000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3321000	USD
CY2019Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2019Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-75652000	USD
CY2020Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	69143000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	525000	USD
CY2020Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	164974000	USD
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	33159000	USD
CY2019Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1633000	USD
CY2019Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	2706000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2072000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37003000	USD
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	29968000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	33778000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	5466000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	6077000	USD
CY2019Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	39461000	USD
CY2020Q1	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	43688000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	12537000	USD
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	2135398000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13323000	USD
CY2020Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	2231903000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	106626000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	3060270000	USD
CY2020Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	188219000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	5684000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	5740000	USD
CY2019Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	4777000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	4957000	USD
CY2019Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	907000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3732554000	USD
CY2019Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	459000	USD
CY2020Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	756000	USD
CY2019Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	0	USD
CY2020Q1	us-gaap	Liabilities Liabilities	3220814000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3577260000	USD
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	27000	USD
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	27275000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	28263000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27475000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2559779000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	2581222000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5619000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3161000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31263000	USD
CY2019Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	549000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	491000	USD
CY2020Q1	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	3929000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	67629000	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	82741000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	728000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	769000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	77000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-80552000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144935000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24510000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97199000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10297000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12165000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	10267000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	10555000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	83000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	118000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	819055000	USD
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	791563000	USD
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	22759000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	23854000	USD
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	9186000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	9585000	USD
CY2019Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1484000	USD
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	521000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2573751000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2607424000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	32238000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	74759000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	13000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2368000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2079000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1168000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	4961000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5682000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	7711000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	4329000	USD
CY2019Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1009000	USD
CY2020Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	662000	USD
CY2019Q4	us-gaap	Other Investments OtherInvestments	24072000	USD
CY2020Q1	us-gaap	Other Investments OtherInvestments	27176000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	21728000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15197000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	19064000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	38188000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	39607000	USD
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1783000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1412000	USD
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2019Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	36747000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	102715000	USD
CY2019Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	63000	USD
CY2020Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3673000	USD
CY2019Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	77000	USD
CY2019Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2020Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	148000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	215000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20000000	USD
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10636000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17931000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	8076000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	37338000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	103950000	USD
CY2019Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	75000000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	698000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	851000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	10350000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10673000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56469000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60276000	USD
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	200000	USD
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1341	shares
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3000000	USD
CY2019Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	200000	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1200000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3000000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	148000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	64000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9000000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	199005000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	215000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	698000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	203385000	USD
CY2019Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	319000	USD
CY2020Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	559000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1108000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1299000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1400000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16671	shares
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	75000000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	851000	USD
CY2019Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	5682000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	15197000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	516262000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	510971000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	387352000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	399593000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	516990000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	511740000	USD
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	297000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	285000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9758351	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9758000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10800636	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10801000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9461000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9461485	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10516000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10515778	shares
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ACL-Loans represents management’s estimate of expected credit losses in the Company’s loan portfolio at the balance sheet date. To assess the appropriateness of the ACL-Loans, an allocation methodology is applied by Nicolet which focuses on evaluation of qualitative and environmental factors, including but not limited to: (i) evaluation of facts and issues related to specific loans; (ii) management’s ongoing review and grading of the loan portfolio; (iii) consideration of historical loan loss and delinquency experience on each portfolio segment; (iv) trends in past due and nonperforming loans; (v) the risk characteristics of the various loan segments; (vi) changes in the size and character of the loan portfolio; (vii) concentrations of loans to specific borrowers or industries; (viii) existing economic conditions; (ix) the fair value of underlying collateral; and (x) other qualitative and quantitative factors which could affect expected credit losses. Assessing these numerous factors involves significant judgment.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management allocates the ACL-Loans by pools of risk within each loan portfolio segment. The allocation methodology consists of the following components. First, a specific reserve is established for individually evaluated credit-deteriorated loans, which management defines as nonaccrual credit relationships over </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;">, all loans determined to be troubled debt restructurings (“restructured loans”), plus other loans with evidence of credit deterioration. The specific reserve in the ACL-Loans for these credit deteriorated loans is equal to the aggregate collateral or discounted cash flow shortfall. Second, management allocates the ACL-Loans with historical loss rates by loan segment. The loss factors are measured on a quarterly basis and applied to each loan segment based on current loan balances and projected for their expected remaining life. Next, management allocates ACL-Loans using the qualitative factors mentioned above. Consideration is given to those current qualitative or environmental factors that are likely to cause estimated credit losses as of the evaluation date to differ from the historical loss experience of each loan segment. Lastly, management considers reasonable and supportable forecasts to assess the collectability of future cash flows.</font></div></div>
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements have been reclassified to conform to the </font><font style="font-family:inherit;font-size:10pt;">2020</font><font style="font-family:inherit;font-size:10pt;"> presentation.</font></div></div>
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Estimates</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items, the allowance for credit losses, valuation of loans in acquisition transactions, useful lives for depreciation and amortization, fair value of financial instruments, other-than-temporary impairment calculations, valuation of deferred tax assets, uncertain income tax positions and contingencies. Estimates that are particularly susceptible to significant change for the Company include the determination of the allowance for credit losses, the determination and assessment of deferred tax assets and liabilities, and the valuation of loans acquired in acquisition transactions; therefore, these are critical accounting policies. Factors that may cause sensitivity to the aforementioned estimates include but are not limited to: external market factors such as market interest rates and employment rates, changes to operating policies and procedures, changes in applicable banking or tax regulations, and changes to deferred tax estimates. Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual reporting period presented.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There have been no material changes or developments with respect to the assumptions or methodologies that the Company uses when applying what management believes are critical accounting policies and developing critical accounting estimates as disclosed in the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, except as disclosed in Updates to Significant Accounting Policies and Recent Accounting Developments Adopted below.</font></div></div>

Files In Submission

Name	View Source	Status
0001174850-20-000032-index-headers.html	Edgar Link	pending
0001174850-20-000032-index.html	Edgar Link	pending
0001174850-20-000032.txt	Edgar Link	pending
0001174850-20-000032-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ncbs-03312020x10q.htm	Edgar Link	pending
ncbs-03312020x10qxexhibit311.htm	Edgar Link	pending
ncbs-03312020x10qxexhibit312.htm	Edgar Link	pending
ncbs-03312020x10qxexhibit321.htm	Edgar Link	pending
ncbs-03312020x10qxexhibit322.htm	Edgar Link	pending
ncbs-20200331.xml	Edgar Link	completed
ncbs-20200331.xsd	Edgar Link	pending
ncbs-20200331_cal.xml	Edgar Link	unprocessable
ncbs-20200331_def.xml	Edgar Link	unprocessable
ncbs-20200331_lab.xml	Edgar Link	unprocessable
ncbs-20200331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NIC
NICOLET BANKSHARES INC Stock $nic

2020 Q1 Form 10-Q Financial Statement

#000117485020000032 Filed on April 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC NICOLET BANKSHARES INC Stock $nic

2020 Q1 Form 10-Q Financial Statement

#000117485020000032 Filed on April 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC
NICOLET BANKSHARES INC Stock $nic